37
views
0
recommends
+1 Recommend
0 collections
    0
    shares
      • Record: found
      • Abstract: found
      • Article: not found

      Opsonization-Enhanced Antigen Presentation by MR1 Activates Rapid Polyfunctional MAIT Cell Responses Acting as an Effector Arm of Humoral Antibacterial Immunity

      research-article

      Read this article at

      ScienceOpenPublisherPMC
      Bookmark
          There is no author summary for this article yet. Authors can add summaries to their articles on ScienceOpen to make them more accessible to a non-specialist audience.

          Key Points

          • IgG opsonization enhances uptake, processing, and presentation of MR1-restricted Ag.

          • This supports greater sensitivity, kinetics, and magnitude of MAIT cell responses.

          • MAIT cells can function as innate-like effectors of humoral antibacterial immunity.

          Abstract

          Mucosa-associated invariant T (MAIT) cells are innate-like antimicrobial T cells recognizing a breadth of important pathogens via presentation of microbial riboflavin metabolite Ags by MHC class Ib–related (MR1) molecules. However, the interaction of human MAIT cells with adaptive immune responses and the role they may play in settings of vaccinology remain relatively little explored. In this study we investigated the interplay between MAIT cell–mediated antibacterial effector functions and the humoral immune response. IgG opsonization of the model microbe Escherichia coli with pooled human sera markedly enhanced the capacity of monocytic APC to stimulate MAIT cells. This effect included greater sensitivity of recognition and faster response kinetics, as well as a markedly higher polyfunctionality and magnitude of MAIT cell responses involving a range of effector functions. The boost of MAIT cell responses was dependent on strongly enhanced MR1-mediated Ag presentation via increased FcγR-mediated uptake and signaling primarily mediated by FcγRI. To investigate possible translation of this effect to a vaccine setting, sera from human subjects before and after vaccination with the 13-valent–conjugated Streptococcus pneumoniae vaccine were assessed in a MAIT cell activation assay. Interestingly, vaccine-induced Abs enhanced Ag presentation to MAIT cells, resulting in more potent effector responses. These findings indicate that enhancement of Ag presentation by IgG opsonization allows innate-like MAIT cells to mount a faster, stronger, and qualitatively more complex response and to function as an effector arm of vaccine-induced humoral adaptive antibacterial immunity.

          Related collections

          Author and article information

          Journal
          J Immunol
          J. Immunol
          jimmunol
          jimmunol
          JI
          The Journal of Immunology Author Choice
          AAI
          0022-1767
          1550-6606
          1 July 2020
          20 May 2020
          : 205
          : 1
          : 67-77
          Affiliations
          [* ]Center for Infectious Medicine, Department of Medicine, Karolinska Institutet, 14152 Stockholm, Sweden;
          []Division of Clinical Microbiology, Department of Laboratory Medicine, Karolinska Institutet, Huddinge, 14152 Stockholm, Sweden;
          []Infectious Disease Clinic, Immunodeficiency Unit, Karolinska University Hospital, Huddinge, 14186 Stockholm, Sweden; and
          [§ ]Program in Emerging Infectious Diseases, Duke-National University of Singapore Medical School, 169587 Singapore
          Author notes
          Address correspondence and reprint requests to Dr. Johan K. Sandberg, Center for Infectious Medicine, Department of Medicine, Karolinska Institutet, Alfred Nobels Allé 8, 14152 Stockholm, Sweden. E-mail address: johan.sandberg@ 123456ki.se
          Author information
          http://orcid.org/0000-0003-0562-5395
          http://orcid.org/0000-0003-3306-3713
          http://orcid.org/0000-0003-0505-4967
          http://orcid.org/0000-0002-6275-0750
          Article
          PMC7311261 PMC7311261 7311261 ji_2000003
          10.4049/jimmunol.2000003
          7311261
          32434941
          7ebcc3d5-77ff-4fc3-8e17-0af0f23ce165
          Copyright © 2020 by The American Association of Immunologists, Inc.

          This article is distributed under The American Association of Immunologists, Inc., Reuse Terms and Conditions for Author Choice articles.

          History
          : 02 January 2020
          : 30 April 2020
          Page count
          Figures: 6, Tables: 1, Equations: 0, References: 63, Pages: 11
          Funding
          Funded by: Swedish Research Council, DOI https://doi.org/10.13039/501100004359;
          Award ID: 2016-03052
          Funded by: Swedish Cancer Society, DOI https://doi.org/10.13039/501100002794;
          Award ID: CAN 2017/777
          Funded by: Swedish Heart-Lung Foundation, DOI https://doi.org/10.13039/501100003793;
          Award ID: 20180675
          Funded by: Karolinska Institutet Center for Innovative Medicine
          Award ID: 20190732
          Funded by: Karolinska Institutet, DOI https://doi.org/10.13039/501100004047;
          Funded by: National Institute of Diabetes and Kidney Diseases, National Institutes of Health, DOI https://doi.org/10.13039/100000062;
          Award ID: R01DK108350
          Funded by: Swedish Research Council, DOI https://doi.org/10.13039/501100004359;
          Award ID: 2015-00174
          Funded by: Marie Skłodowska Curie Actions
          Award ID: INCA 600398
          Funded by: Fundação para a Ciência e a Tecnologia, DOI https://doi.org/10.13039/501100001871;
          Award ID: SFRH/BD/85290/2012
          Categories
          Clinical and Human Immunology

          Comments

          Comment on this article